Clinical Trials Directory

Trials / Completed

CompletedNCT04102332

Safe Infusion Device in Reducing Occupational Exposure of Nurses

Evaluation of a Safe Infusion Device in Reducing Occupational Exposure of Nurses to Antineoplastic Drugs: a Comparative Prospective Study. CONTAMOINS-1

Status
Completed
Phase
Study type
Observational
Enrollment
120 (actual)
Sponsor
Institut de Cancérologie de la Loire · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Monocentric comparative before / after study to evaluate the efficacy of Safe Infusion Devices (SIDs) in reducing drug exposure to nurses compared to usual perfusion practices.

Detailed description

Despite the decreasing of environmental contamination throughout the anticancer drug circuit, the administration of chemotherapies remains at risk of occupational exposure for nurses. Many medical devices aim at securing administration, but none have been scientifically evaluated to verify the actual improvement. A monocentric comparative before / after study was carried out in an oncology day hospital in order to evaluate the efficacy of Safe Infusion Devices in reducing drug exposure compared to usual perfusion practices (neutral solvent-purged infusers). The rate of nurses' gloves contamination was estimated. The eligible protocols must contain at least one disconnection step and one of the 10 drugs screened. To avoid false negatives, each sample of gloves was contaminated with a drop of topotecan. Association between contamination and other variables was investigated using a multivariate regression analysis. The usual practice leaded to a rate of 58.3% of contaminated samples while Safe Infusion Devices to a rate of 15%: Safe Infusion Devices reduced the risk of gloves contamination by 84% in multivariate analysis (Odds ratio=0.16; 95% confidence interval=0.05-0.47; p\<0.001). Topotecan was identified within 100% of the samples. Only one case of cross-contamination has occurred. Despite the current practice of using neutral solvent-purged infusers, the occupational exposure remains high for nurses and Safe Infusion Devices significantly reduced this risk of exposure. However, glove contamination is only a surrogate endpoint. The results confirmed that the disconnection of empty bags resulted in occupational exposure. Except a contamination due to the leakage of a bag, no cross-contamination was detected. This validated the environmental quality of the cytotoxic drug circuit. Safe Infusion Devices were highly effective but did not completely eliminate exposure.

Conditions

Interventions

TypeNameDescription
DEVICESafe Infusion DeviceSafe infusion device is a different method than usual infusion practices (neutral solvent-purged infusers)

Timeline

Start date
2017-12-12
Primary completion
2018-10-01
Completion
2018-10-08
First posted
2019-09-25
Last updated
2019-09-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04102332. Inclusion in this directory is not an endorsement.